Literature DB >> 26837482

Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.

Soumita Bagchi1, Geetika Singh2, Rajni Yadav3, Mani Kalaivani4, Sandeep Mahajan5, Dipankar Bhowmik6, Amit Dinda7, Sanjay Kumar Agarwal8.   

Abstract

BACKGROUND: IgA nephropathy (IgAN) is known to have an aggressive course in Asians. There is a paucity of data regarding the Oxford classification pattern of Indian patients with IgAN. This study aims to characterize the clinical and histopathologic profile of these patients.
METHODS: All patients diagnosed to have primary IgAN by kidney biopsy in the nephrology department from July 2009 to July 2014 were included in this study. All kidney biopsies were reviewed and the MEST score was assigned as per the Oxford classification. The clinical features and Oxford classification score of patients were characterized.
RESULTS: Nephrotic range proteinuria (NRP) (65/103, 63.1%) with or without edema was the commonest presentation. 67.0% patients had eGFR ≥ 60 mL/min and 16.5% patients had eGFR < 30 mL/min. Of the 103 patients, 80 (77.7%) had M1, 10 (9.7%) had E1, 45 (43.7%) had S1 and 41 (39.8%) had T1/T2 lesions by the Oxford criteria and 11 (10.7%) patients had crescents. 62 patients had eGFR ≥ 30 mL/min and follow up for at least 6 months (median -17.7 (6-65.1) months) of whom 52(83.9%) had received ACEi/ARBs and 38 (61.3%) had received immunosuppression. 11/62 (17.7%) patients developed renal worsening in this period of which 7 (11.3%) developed end stage kidney disease (ESKD).
CONCLUSION: Indian patients with primary IgA nephropathy have a unique profile. They commonly present with nephrotic range proteinuria. A significant proportion of these patients have normal renal function despite heavy proteinuria. Mesangial proliferative lesions are predominant with a paucity of endocapillary proliferation and crescents compared to other Asian populations. Immunosuppressive use is more common in Indian patients.

Entities:  

Keywords:  Clinical profile; IgA nephropathy; Oxford classification

Mesh:

Substances:

Year:  2016        PMID: 26837482     DOI: 10.3109/0886022X.2016.1138817

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients.

Authors:  Soumita Bagchi; Ashish Datt Upadhyay; Adarsh Barwad; Geetika Singh; Arunkumar Subbiah; Raj Kanwar Yadav; Sandeep Mahajan; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Kidney Int Rep       Date:  2022-03-24

2.  Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.

Authors:  Soumita Bagchi; Raghavendra Lingaiah; Kalaivani Mani; Adarsh Barwad; Geetika Singh; Veena Balooni; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

Review 3.  Recurrent Glomerulonephritis in the Kidney Allograft.

Authors:  Shane A Bobart; Mariam P Alexander; Andrew Bentall
Journal:  Indian J Nephrol       Date:  2020-11-30

4.  Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study.

Authors:  Soumita Bagchi; Kalaivani Mani; Anitha Swamy; Adarsh Barwad; Geetika Singh; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Kidney Int Rep       Date:  2021-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.